Literature DB >> 1702928

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.

J Grøndahl-Hansen1, E Ralfkiaer, L T Kirkeby, P Kristensen, L R Lund, K Danø.   

Abstract

Human colon adenocarcinomas and adjacent normal colon tissues were stained immunohistochemically with three different monoclonal antibodies and one preparation of polyclonal antibodies against each of the two plasminogen activators, uPA (urokinase type) and tPA (tissue type). The staining patterns seen with the respective sets of antibodies were identical. In all of 10 cases, staining for uPA in the normal colon tissue was confined to scattered fibroblastlike cells in the lamina propria. Other cells, including epithelial and endothelial cells, were uPA negative. All the tumor infiltrates contained many more uPA-positive cells than the normal tissues, but the staining was confined to fibroblastlike cells and endothelial cells in the tumor stroma, while no staining of the malignant epithelial cells was detected. Analysis for uPA by enzyme-linked immunosorbent assay (ELISA) in four cases showed an average uPA content of 0.15 ng uPA/mg protein in the normal colon tissues and 1.6 ng uPA/mg protein in the tumors. Tissue-type plasminogen activator immunoreactivity was confined to endothelial cells in both the normal colon tissue and in the colon carcinomas. These findings may indicate that colon cancer cells recruit stromal cells to produce uPA involved in degradation of the extracellular matrix during invasive growth.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702928      PMCID: PMC1886060     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.

Authors:  J Grøndahl-Hansen; E Ralfkiaer; L S Nielsen; P Kristensen; G Frentz; K Danø
Journal:  J Invest Dermatol       Date:  1987-01       Impact factor: 8.551

Review 2.  Proteolytic degradation of extracellular matrix in tumor invasion.

Authors:  K Tryggvason; M Höyhtyä; T Salo
Journal:  Biochim Biophys Acta       Date:  1987-11-25

3.  Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.

Authors:  V J Hearing; L W Law; A Corti; E Appella; F Blasi
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

4.  Plasminogen activators in experimental colorectal neoplasia: a role in the adenoma-carcinoma sequence?

Authors:  J S Gelister; M R Lewin; H E Driver; F Savage; M Mahmoud; P J Gaffney; P B Boulos
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

5.  Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material.

Authors:  D Boyd; G Florent; S Chakrabarty; D Brattain; M G Brattain
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

6.  Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes.

Authors:  V Ellis; M F Scully; V V Kakkar
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

7.  Immunohistochemical localization of urokinase-type plasminogen activator in Sertoli cells and tissue-type plasminogen activator in spermatogenic cells in the rat seminiferous epithelium.

Authors:  K K Vihko; P Kristensen; K Danø; M Parvinen
Journal:  Dev Biol       Date:  1988-03       Impact factor: 3.582

8.  Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.

Authors:  J Grøndahl-Hansen; N Agerlin; P Munkholm-Larsen; F Bach; L S Nielsen; P Dombernowsky; K Danø
Journal:  J Lab Clin Med       Date:  1988-01

Review 9.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.

Authors:  F Blasi; J D Vassalli; K Danø
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

10.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.

Authors:  R W Stephens; J Pöllänen; H Tapiovaara; K C Leung; P S Sim; E M Salonen; E Rønne; N Behrendt; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

View more
  44 in total

1.  Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.

Authors:  D Albo; D H Berger; J Vogel; G P Tuszynski
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

2.  Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

Authors:  Y Friedmann; I Vlodavsky; H Aingorn; A Aviv; T Peretz; I Pecker; O Pappo
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.

Authors:  N Wernert; M B Raes; P Lassalle; M P Dehouck; B Gosselin; B Vandenbunder; D Stehelin
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

4.  Targeting zymogen activation to control the matriptase-prostasin proteolytic cascade.

Authors:  Zhenghong Xu; Ya-Wen Chen; Aruna Battu; Paul Wilder; David Weber; Wenbo Yu; Alexander D Mackerell; Li-Mei Chen; Karl X Chai; Michael D Johnson; Chen-Yong Lin
Journal:  J Med Chem       Date:  2011-10-12       Impact factor: 7.446

5.  Tissue-type plasminogen activator activity in morphologically normal tissues adjacent to gastrointestinal carcinomas is associated with the degree of tumor progression.

Authors:  Gabriel Scicolone; Viviana Sanchez; Liliana Vauthay; Federico Fuentes; Alejandro Scicolone; Lorenzo Scicolone; Melina Rapacioli; Vladimir Flores
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-21       Impact factor: 4.553

6.  Alpha 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells.

Authors:  R W Stephens; H Tapiovaara; T Reisberg; J Bizik; A Vaheri
Journal:  Cell Regul       Date:  1991-12

7.  Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.

Authors:  P H Quax; N Pedersen; M T Masucci; E J Weening-Verhoeff; K Danø; J H Verheijen; F Blasi
Journal:  Cell Regul       Date:  1991-10

8.  Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

Authors:  T J de Vries; P H Quax; M Denijn; K N Verrijp; J H Verheijen; H W Verspaget; U H Weidle; D J Ruiter; G N van Muijen
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

9.  Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.

Authors:  L R Lund; V Ellis; E Rønne; C Pyke; K Danø
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

10.  Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.

Authors:  P R Gibson; I Birchall; O Rosella; V Albert; C F Finch; D H Barkla; G P Young
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.